| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 610.80M | 618.20M | 657.50M | 913.60M | 786.60M |
| Gross Profit | 85.30M | -71.60M | 100.60M | 194.30M | 166.70M |
| EBITDA | 23.00M | -122.80M | 39.50M | 42.80M | 100.20M |
| Net Income | 2.20M | -103.50M | 17.90M | 26.40M | 70.90M |
Balance Sheet | |||||
| Total Assets | 1.42B | 1.44B | 1.53B | 1.58B | 1.61B |
| Cash, Cash Equivalents and Short-Term Investments | 126.20M | 74.80M | 163.70M | 374.90M | 351.80M |
| Total Debt | 173.40M | 94.30M | 104.10M | 101.00M | 102.50M |
| Total Liabilities | 702.70M | 713.30M | 674.00M | 696.10M | 706.80M |
| Stockholders Equity | 718.10M | 728.90M | 856.30M | 883.10M | 901.60M |
Cash Flow | |||||
| Free Cash Flow | -11.00M | -69.20M | -167.40M | 54.10M | 126.40M |
| Operating Cash Flow | -11.00M | -67.80M | -165.60M | 54.20M | 126.60M |
| Investing Cash Flow | -7.40M | 25.00M | 1.60M | 11.90M | -700.00K |
| Financing Cash Flow | 69.60M | -46.00M | -47.00M | -43.20M | -14.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £3.65B | 13.20 | 2.73% | 4.73% | 33.83% | 15.11% | |
63 Neutral | £2.98B | 37.90 | 2.40% | 8.95% | 4.21% | -65.57% | |
62 Neutral | £2.22B | 8.04 | 4.43% | 2.62% | 16.91% | 20.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £3.53B | 15.22 | 8.05% | 4.54% | 16.74% | -0.16% | |
54 Neutral | £1.04B | 15.19 | 4.20% | ― | -0.57% | -104.08% | |
43 Neutral | £266.99M | 192.98 | 0.30% | 1.79% | -3.50% | -176.18% |